Latest Phosphoinositide 3-kinase inhibitor Stories
- Array regained worldwide rights to binimetinib and acquired worldwide rights to encorafenib - BOULDER, Colo., May 4, 2015 /PRNewswire/ -- Array BioPharma Inc.
PHILADELPHIA, April 18, 2015 /PRNewswire/ -- Aurigene and its partner Curis, Inc.
LONDON, Nov. 27, 2014 /PRNewswire/ -- INTRODUCTIONTargeted therapeutics is fast emerging as the key focus area in biopharmaceutical industry.
LONDON, Oct. 14, 2014 /PRNewswire/ -- REPORT HIGHLIGHTSThe global market for signal transduction therapies/inhibitors (JAK and PI3K) reached $173.5 million in 2012.
Array planning for potential return of MEK inhibitor BOULDER, Colo., Aug. 12, 2014 /PRNewswire/ -- Array BioPharma Inc.
- More than 50 abstracts highlight breadth and depth of Novartis Oncology pipeline and ability to test various combinations early to target multiple pathways EAST HANOVER, N.J., April 3, 2014
- A woman chauffeur.
- A woman who operates an automobile.